Bulletin
Investor Alert

Medipharm Labs Corp.

OTC: MEDIF

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Mar 5, 2021, 3:59 p.m.

/zigman2/quotes/203412746/composite

$

0.38

Change

+0.0077 +2.06%

Volume

Volume 1.81m

Quotes are delayed by 20 min

/zigman2/quotes/203412746/composite

Previous close

$ 0.37

$ 0.38

Change

+0.0077 +2.06%

Day low

Day high

$0.35

$0.39

Open

52 week low

52 week high

$0.35

$1.86

Open

Annual Financials for Medipharm Labs Corp.

Fiscal year is January-December. All values CAD millions. 20182019 5-year trend
Sales/Revenue ---10.2M129.25M
Cost of Goods Sold (COGS) incl. D&A ---7.08M87.55M
COGS excluding D&A ---6.1M85.02M
Depreciation & Amortization Expense ---982,0002.53M
Depreciation ---982,0002.53M
Amortization of Intangibles -----
Gross Income ---3.12M41.7M
20182019 5-year trend
SG&A Expense ---6.87M33.85M
Research & Development ---261,000621,000
Other SG&A ---6.61M33.23M
Other Operating Expense -----
Unusual Expense ---4.23M480,000
EBIT after Unusual Expense ---(7.98M)7.38M
Non Operating Income/Expense ---(63,000)(413,000)
Non-Operating Interest Income ---64,000486,000
Equity in Affiliates (Pretax) -----
Interest Expense ---485,000699,000
Gross Interest Expense ---485,000699,000
Interest Capitalized -----
Pretax Income ---(8.47M)6.75M
Income Tax ----5.62M
Income Tax - Current Domestic ----5.04M
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic ----578,000
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income ---(8.47M)1.13M
Minority Interest Expense ---(80,000)(514,000)
Net Income ---(8.39M)1.65M
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries ---(8.39M)1.65M
Preferred Dividends -----
Net Income Available to Common ---(8.39M)1.65M
EPS (Basic) ---(0.12)0.01
Basic Shares Outstanding ---72.59M120M
EPS (Diluted) ---(0.12)0.01
Diluted Shares Outstanding ---72.59M134.63M
EBITDA ---(2.77M)10.39M
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.